Abstract Background: Historical concerns over radiation-induced toxicities frequently lead to the unwarranted omission of adjuvant radiotherapy (RT) in breast cancer patients with systemic lupus erythematosus (SLE). However, modern precision RT and assessments prioritizing concurrent disease activity challenge this perspective. Case presentation: We present a 31-year-old woman with early-stage left-sided breast cancer (pTisN0M0) and a history of life-threatening SLE.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xunzhang
Contact Xunzhang, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack